loading page

Remdesivir is least likely to be effective for safe treatment of COVID-19: A pharmacovigilant point of view    
  • Mina Kelleni
Mina Kelleni

Corresponding Author:[email protected]

Author Profile


This manuscript has been published on the 29 th of May 2020 by the honorable BMJ as a rapid response to a related article. However since a DOI has not been assigned and two subsequent manuscripts have cited it, I'm preprinting a copy wishing it might reach all the interested colleagues and researchers in an easier way.